SINGAPORE - A new drug currently being developed by local biotech company Aslan Pharmaceuticals may be able to provide those with eczema complete relief from their symptoms.
The company announced the enrolment of the first patient in its clinical trials on Tuesday (Oct 22).
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
